Evoxac (Daiichi Sankyo Pharma Development)
Welcome to the PulseAid listing for the Evoxac drug offered from Daiichi Sankyo Pharma Development. This Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Daiichi Sankyo Pharma Development |
| NON-PROPRIETARY NAME: | cevimeline hydrochloride |
| SUBSTANCE NAME: | CEVIMELINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-01-12 |
| END MARKETING DATE: | 0000-00-00 |
Evoxac HUMAN PRESCRIPTION DRUG Details:
| Item Description | Evoxac from Daiichi Sankyo Pharma Development |
| LABELER NAME: | Daiichi Sankyo Pharma Development |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(mg/1) |
| START MARKETING DATE: | 2000-01-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63395-201_3e7f5395-9fff-44d8-b44e-2c0e2c182f70 |
| PRODUCT NDC: | 63395-201 |
| APPLICATION NUMBER: | NDA020989 |
Other CEVIMELINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
